Understanding and manipulating the epigenetic networks that define Osteosarcoma

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Osteosarcoma is the most common type of bone cancer and the fifth most common form of cancer in children. Although osteosarcoma begins in bones, the cancer often spreads to other parts of the body. Patients have a very poor chance of survival if their cancer has spread. We will use mouse and human models of osteosarcoma to improve our understanding of how the cancer is different from the normal bone forming cells. This information will help us to find new treatments to improve patient outcomes.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Postgraduate Scholarships

Funding Amount: $80,467.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Epigenetics (incl. Genome Methylation and Epigenomics)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cancer therapy | epigenetics | metastatic cancer | mouse models | osteosarcoma